High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: A pediatric oncology group study

Journal of Clinical Oncology

Volumn 9, Issue 1, 1991, Pages 152-158

  Pole, John Graham ^a   Casper, James ^b   Elfenbein, Gerald ^b   Gee, Adrian ^b   Gross, Samuel ^b   Janssen, William ^b   Koch, Penelope ^b   Marcus, Robert ^b   Pick, Terry ^b   Shuster, Jonathan ^b   Spruce, Wayne ^b   Thomas, Paul ^b   Yeager, Andrew ^b  

^a Pediatric Oncology Group   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MELPHALAN;

ADOLESCENT; ARTICLE; CHILD; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEUROBLASTOMA; PRIORITY JOURNAL; WHOLE BODY RADIATION;

ADOLESCENT; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMAN; INFANT; MALE; MELPHALAN; NEUROBLASTOMA; PILOT PROJECTS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE;

EID: 0026083733     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.1.152     Document Type: Article

References (34)

1. Evans AE, D'Angio GJ, Knudson AG, et al (eds): Advances in Neuroblastoma Research 2. New York, NY, Liss, 1988
2. Hayes FA, Green AA: Neuroblastoma. Pediatr Ann 12:366-374, 1983
3. Shafford EA, Rogers DW, Pritchard J: Advanced neuroblastoma: Improved response rate using a multi-agent regimen including cisplatin and VM26. J Clin Oncol 2:742-747, 1984
4. Hartmann O, Pinkerton CR, Philip T, et al: Very high-dose cisplatin and etoposide in children with untreated advanced neuroblastoma. J Clin Oncol 6:44-50, 1988
5. Rosen EM, Cassady JR, Frantz CN, et al: Neuroblastoma: The Joint Center for Radiation Therapy/Dana Farber Cancer Institute experience. J Clin Oncol 2:719-732, 1984
6. Evans AE, D'Angio GJ, Propert K, et al: Prognostic factors in neuroblastoma. Cancer 59:1853-1859, 1987
7. Green AA, Hayes FA, Hustu HO: Sequential cyclophosphamide and doxorubicin for induction of complete remission in children with disseminated neuroblastoma. Cancer 48:2310-2317, 1981
8. Simone J: The treatment of neuroblastoma. J Clin Oncol 2:718, 1984 (editorial)
9. D'Angio GJ, August C, Elkins W, et al: Metastatic neuroblastoma managed by supralethal therapy and bone marrow reconstitution, in Evans A, D'Angio GJ, Seeger RC (eds): Advances in Neuroblastoma Research. New York, NY, Alan Liss, 1985, pp 557-563
10. August CS, Serota FT, Koch PA, et al: Treatment of advanced neuroblastoma with supralethal chemotherapy, radiation, and allogeneic or autologous marrow reconstitution. J Clin Oncol 2:609-616, 1984
11. Pritchard J, McElwain TJ, Graham Pole J: High-dose melphalan with autologous marrow for treatment of advanced neuroblastoma. Br J Cancer 45:86-94, 1982
12. Skipper HE: Criteria associated with destruction of leukemia and solid tumor cells in animals. Cancer Res 27:2636-2645, 1967
13. Bruce WR, Meeker BE, Valeriote FA: Comparison of the sensitivity of normal hematopoietic and transplanted lymphoma colony-forming cells to chemotherapeutic agents administered in vivo. J Natl Cancer Inst 37:233-245, 1966
14. Frei E, Antman K, Teicher B, et al: Bone marrow autotransplantation for solid tumors - Prospects. J Clin Oncol 7:515-526, 1989
15. Chabner BA: Pharmacological considerations in autologous bone marrow transplant regimens, in Gale RP, Fox FC (eds): Biology of Bone Marrow Transplantation. San Diego, CA, 1980, Academic Press, pp 137-143
16. Treleaven JG, Gibson FM, Ugelstad J, et al: Removal of neuroblastoma cells from bone marrow with monoclonal antibodies conjugated to magnetic microspheres. Lancet 1:70-73, 1984
17. Gee AP, Graham Pole J, Lee C, et al: Transplantation for neuroblastoma using immunomagnetically purged autologous bone marrow, in Dicke K, Spitzer G, Jagannath S, et al (eds): Proc 3rd Internat Symp Autologous Bone Marrow Transplantation. 1987, pp 425-431
18. Peto R, Peto J: Asymptotically efficient rank invari-ant test procedures. J Roy Stat Soc Series A 135:185-198, 1972
19. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
20. Peto R, Pike MC, Armitage P, et al: Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 35:1-39, 1977
21. Shuster J: Exact B and CONF: Exact unconditional procedures for binomial data. Am Stat 42:234, 1988
22. Graham Pole J, Gee AP, Gross S, et al: Bone marrow transplantation for advanced neuroblastoma: A multicenter POG pilot study, in Evans AE, D'Angio AJ, Knudson AF, et al (eds): Advances in Neuroblastoma Research 2. New York, NY, Alan Liss, 1988, pp 215-223
23. Graham Pole J, Lazarus HM, Herzig RH: High-dose melphalan therapy for the treatment of children with refractory neuroblastoma and Ewing's sarcoma. Am J Pediatr Hematol Oncol 6:17-26, 1984
24. Philip T, Bernard JM, Zucker R, et al: High-dose chemoradiotherapy with bone marrow transplantation as consolidation treatment in neuroblastoma: An unselected group of stage IV patients over 1 year of age. J Clin Oncol 5:266-271, 1987
25. Seeger RC, Reynolds CP, Vo DD, et al: Depletion of neuroblastoma cells from bone marrow with monoclonal antibodies and magnetic immunobeads. Prog Clin Biol Res 175:443-458, 1985
26. Graham Pole J: The role of marrow autografting in neuroblastoma. Bone Marrow Transplant 4:3, 1989 (editorial)
27. Hartmann O, Benhamon E, Beaujean F, et al: High-dose busulphan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children. J Clin Oncol 4:1804-1810, 1986
28. Pinkerton R, Philip T, Bouffet E: Autologous bone marrow transplantation in pediatric solid tumors. Clin Hematol 15:187-203, 1986
29. Jacobson HM, Marcus RB, Thar TR, et al: Pediatric neuroblastoma: Postoperative radiation therapy using less than 2,000 rad. Int J Radiat Oncol 9:501-505, 1983
30. McCulloch EA, Till JE: The sensitivity of cells from normal mouse bone marrow cells to gamma irradiation in vitro and in vivo. Radiat Res 16:822-832, 1962
31. Peters LS, Withers R, Cunditt JH, et al: Radiobiological considerations in the use of total body irradiation for bone marrow transplantation. Radiology 131:243-247, 1979
32. Hagenbeck J, Martens A, Schultz FW: How to prevent a leukemia relapse after bone marrow transplantation in acute leukemia: Preclinical and clinical model studies, in Baum SJ, Dicke KA, Lotzoua E, et al: Experimental Hematology Today. New York, NY, Springer Verlag, 1988, pp 147-151
33. Bates S, Mickley L, Chen Y: Expression of a drug resistance gene in human neuroblastoma cell lines: Modulation by retinoic acid-induced differentation. Mol Cell Biol 9:4337-4344, 1989
34. Graham Pole J, August C, Ramsay N, et al: Is there an advantage to allogeneic over autologous marrow transplantation in patients with metastatic neuroblastoma? Exp Hematol 17:586, 1989 (abstr)